4 free views remaining today
Schnyder corneal dystrophy
ICD-10 Codes
Related ICD-10:
Description
Schnyder Corneal Dystrophy: A Rare Eye Disease
Schnyder corneal dystrophy (SCD) is a rare and progressive eye disease characterized by the abnormal deposition of cholesterol and phospholipid crystals in the central corneal stroma. This leads to corneal clouding or crystalline deposits, which can cause vision problems.
Key Features:
- Bilateral Corneal Opacification: SCD affects both eyes, causing a progressive opacification (clouding) of the cornea.
- Cholesterol and Phospholipid Deposits: The disease is characterized by the abnormal deposition of cholesterol and phospholipid crystals in the central corneal stroma.
- Corneal Arcus Formation: In later stages, patients may develop a dense corneal arcus (a yellowish ring-like deposit) at the outer edge of the cornea.
Causes and Genetics:
- Autosomal Dominant Inheritance: SCD is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the disease.
- Rare Autosomal Dominant Disorder: The disease is rare and affects approximately 1 in 100,000 people worldwide.
Symptoms:
- Vision Problems: Patients with SCD may experience vision problems due to corneal clouding or crystalline deposits.
- Corneal Opacity: The disease can cause a progressive opacity of the cornea, which can lead to vision loss if left untreated.
References:
- [1] Mar 21, 2024 — Disease Entity Schnyder stromal dystrophy is a progressive bilateral corneal opacification that results from abnormal deposition of cholesterol ...
- [3] Jun 10, 2020 — Schnyder corneal dystrophy (SCD), also called Schnyder crystalline corneal dystrophy (SCCD), is a rare autosomal-dominant stromal dystrophy.
- [5] It results in deposition of cholesterol and phospholipid crystals in the central corneal stroma. Later, the patients develop a dense corneal arcus, and ...
- [6] Schnyder corneal dystrophy (SCCD), also known as Schnyder crystalline corneal dystrophy, is an autosomal dominant eye disease characterized by abnormal ...
Additional Characteristics
- Autosomal Dominant Inheritance
- Vision Problems
- Schnyder Corneal Dystrophy
- Bilateral Corneal Opacification
- Cholesterol and Phospholipid Deposits
- Corneal Arcus Formation
- Corneal Opacity
Signs and Symptoms
Common Signs and Symptoms of Schnyder Corneal Dystrophy
Schnyder corneal dystrophy (SCD), also known as Schnyder crystalline corneal dystrophy (SCCD), is a rare autosomal-dominant stromal dystrophy. The most common symptoms include:
- Visual disturbances: Patients may experience blurred vision or clouded vision due to the progressive opacification of the cornea [2].
- Glare and light sensitivity: As the corneal crystals accumulate, patients may complain of increasing glare and light scatter, which can cause significant visual impairment [7][8].
- Corneal opacification: The cornea becomes increasingly opaque, leading to a decrease in visual acuity [5].
In some cases, patients may not experience any symptoms (asymptomatic) or may have mild symptoms. However, as the disease progresses, the symptoms can become more pronounced and affect daily life.
Additional Symptoms
- Corneal arcus: Patients may develop a dense corneal arcus, which is a white or grayish discoloration of the peripheral cornea [9].
- Midperipheral corneal opacification: The central cornea remains clear, but the mid-periphery becomes increasingly opaque [9].
It's essential to note that Schnyder corneal dystrophy can be asymptomatic in some individuals, and symptoms may not appear until later stages of the disease.
References: [1] Not applicable [2] 3. Nov 2, 2022 — Corneal dystrophies are a group of rare diseases that cause build-up of foreign matter in the layers of the cornea. [5] 5. Corneal dystrophies may not cause symptoms (asymptomatic) in some individuals; in others they may cause significant vision impairment. The age of onset and ... [7] 7. The consequent corneal opacification is progressive and bilateral, resulting in glare and loss of vision that is postulated to be caused by light scattering. [8] by A Sarosiak · 2018 · Cited by 6 — Patients complain of decreasing visual acuity (VA) and glare which is caused by light scattering from the surfaces of corneal crystals. In order to recover ... [9] Later, the patients develop a dense corneal arcus, and eventually midperipheral corneal opacification and decreased corneal sensation.
Additional Symptoms
- Visual disturbances
- Corneal opacification
- Corneal arcus
- Midperipheral corneal opacification
- light sensitivity
Diagnostic Tests
Schnyder corneal dystrophy can be diagnosed through various diagnostic tests, which are essential for an accurate diagnosis and treatment plan.
Clinical Diagnosis The condition can often be diagnosed clinically, especially during the first decade of life [5]. A ring-shaped yellow-white opacity composed of innumerable fine needle-shaped crystals forms in Bowman's layer and the anterior stroma, which is a characteristic feature of Schnyder corneal dystrophy [6].
Genetic Testing Genetic testing plays a crucial role in diagnosing Schnyder Crystalline Corneal Dystrophy (SCCD) [8]. This test can confirm the diagnosis, facilitate genetic counseling, and provide information on the inheritance pattern of the condition.
Slit Lamp Examination A slit lamp examination is an essential tool for diagnosing Schnyder corneal dystrophy. The exam involves using a special microscope to examine the cornea and detect any abnormalities [3]. This test can help identify the characteristic crystals in Bowman's layer and the anterior stroma.
Other Diagnostic Tests While not specifically mentioned in the context, other diagnostic tests such as high-resolution multimodal imaging may also be used to diagnose Schnyder corneal dystrophy [7].
In summary, the diagnostic tests for Schnyder corneal dystrophy include:
- Clinical diagnosis
- Genetic testing
- Slit lamp examination
- High-resolution multimodal imaging (may be used)
References: [3] - The most important tool is an eye exam, especially specific parts of it like a slit lamp exam. [5] - While Schnyder corneal dystrophy may be diagnosed easily during the first decade of life, the diagnosis Schnyder corneal dystrophy sine crystals can be challenging. [6] - 22). Diagnostic methods. Typically, a ring-shaped yellow-white opacity composed of innumerable fine needle-shaped crystals forms in Bowman layer and the ... [7] - by W Ghazal · 2020 · Cited by 7 — High-resolution multimodal imaging demonstrates the characteristic features of SCD which involve both the corneal epithelium and stroma. [8] - Genetic testing plays a crucial role in diagnosing Schnyder Crystalline Corneal Dystrophy (SCCD). Learn about SCCD symptoms, diagnosis, and how genetic ...
Additional Diagnostic Tests
- Slit lamp examination
- Genetic testing
- Clinical diagnosis
- High-resolution multimodal imaging
Treatment
Current Treatment Options for Schnyder Corneal Dystrophy
Schnyder corneal dystrophy (SCD) is a rare form of stromal corneal dystrophy characterized by corneal clouding or crystals within the corneal stroma. While there is no local or systemic medical treatment available to stop the progression of corneal lipid deposition or alter serum cholesterol levels, various treatments can help manage symptoms and improve quality of life.
- Medications: Taking medications exactly as prescribed is critical if you receive any kind of treatment for SCD. However, specific medications are not mentioned in the search results.
- Phototherapeutic Keratectomy (PTK): PTK has been reported to be effective in treating superficial cholesterol crystals in the cornea [3][10]. This procedure involves using an excimer laser to remove or modify the affected area of the cornea.
Other Treatment Options
As symptoms worsen, other treatment options may include:
- Eye drops and ointments: These can help manage symptoms such as glare and discomfort [8].
- Corneal transplantation: In severe cases, corneal transplantation may be necessary due to significant visual impairment or discomfort caused by the disease [4].
Important Considerations
It's essential to note that each patient's experience with SCD is unique, and treatment plans should be tailored to individual needs. Consultation with an eye care professional is crucial for determining the best course of action.
References:
[1] Jun 10, 2020 — No local or systemic medical treatment is available to stop the progression of corneal lipid deposition or the alteration of serum cholesterol levels. [4] Jun 10, 2020 — Contrary to prior reports, many patients with Schnyder corneal dystrophy eventually require corneal transplantation because of glare and ... [8] Nov 2, 2022 — As your symptoms get worse, other treatment options include eye drops and ointments. If your vision is bad enough, the doctor may suggest a ... [10] by CA Chen · 2023 · Cited by 1 — Phototherapeutic keratectomy (PTK) has been reported to be effective in the treatment of SCD. Most studies have indicated that PTK was applied for superficial ...
Recommended Medications
- Medications
- Phototherapeutic Keratectomy (PTK)
- Eye drops and ointments
- Corneal transplantation
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Schnyder Corneal Dystrophy
Schnyder corneal dystrophy (SCD) is a rare form of stromal corneal dystrophy characterized by abnormally increased deposition of cholesterol and phospholipids in the cornea. When diagnosing SCD, it's essential to consider other conditions that may present with similar symptoms.
Conditions to Consider:
- Cystinosis: A rare genetic disorder that can cause crystalline deposits in the cornea, similar to those found in SCD [1].
- Dysproteinemias: A group of disorders characterized by abnormal protein production, which can lead to crystalline deposits in the cornea [3].
- Hyperuricemia: Elevated levels of uric acid in the blood, which can cause crystalline deposits in the cornea [3].
- Multiple Myeloma: A type of cancer that can produce abnormal proteins leading to crystalline deposits in the cornea [3].
- Porphyria: A group of disorders characterized by abnormal production of heme, which can lead to crystalline deposits in the cornea [3].
Other Considerations:
- Monoclonal Gammopathy: A condition where a single type of antibody is produced in excess, leading to crystalline deposits in the cornea [7].
- Cystinosis: A rare genetic disorder that can cause crystalline deposits in the cornea, similar to those found in SCD [1].
Age Considerations:
- Schnyder corneal dystrophy can develop as late as age 30, and Pre-Descemet corneal dystrophy usually develops after age 30 [9].
These conditions should be considered in the differential diagnosis of Schnyder corneal dystrophy. A thorough evaluation by an eye care professional is necessary to determine the correct diagnosis.
References:
[1] - Context result 1 [3] - Context result 3 [7] - Context result 7 [9] - Context result 9
Additional Differential Diagnoses
Additional Information
- core#notation
- DOID:0060456
- rdf-schema#label
- Schnyder corneal dystrophy
- rdf-schema#subClassOf
- t340908
- relatedICD
- http://example.org/icd10/H16.433
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#creation_date
- 2015-10-16T18:01:14Z
- oboInOwl#id
- DOID:0060456
- oboInOwl#created_by
- elvira
- oboInOwl#hasDbXref
- UMLS_CUI:C0271287
- IAO_0000115
- A stromal dystrophy that is characterized by abnormal deposition of cholesterol and phospholipids in the cornea and that has_material_basis_in heterozygous mutation in the UBAID1 gene on chromosome 1p36.
- oboInOwl#hasExactSynonym
- Schnyder crystalline corneal dystrophy
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1482
- owl#annotatedSource
- t341310
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.